NEVVI Medicare utilization intelligence

← back

DACOSTA, NOSHIRMD NPI 1154300622 Clinician

Medical Oncology · SMITHTOWN, NY

Specialty Medical Oncology — from billed Medicare claims
In practice about 41 years since medical school (class of 1985, self-reported to CMS)
Location SMITHTOWN, NY · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 110 codes billed · 107,089 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
NORTH SHORE HEMATOLOGY ONCOLOGY ASSOCIATES PC
2019–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2020-01

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Unlock to see the figure.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J1439 Injection, ferric carboxymaltose, 1 mg
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use)
88185 Flow cytometry technique for dna or cell analysis, each additional marker
J9271 Injection, pembrolizumab, 1 mg
J1756 Injection, iron sucrose, 1 mg
J0897 Injection, denosumab, 1 mg
36415 Insertion of needle into vein for collection of blood sample
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
80053 Blood test, comprehensive group of blood chemicals
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
J1100 Injection, dexamethasone sodium phosphate, 1 mg
83615 Lactate dehydrogenase (enzyme) level
99490 Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month
83735 Magnesium level
84100 Phosphate level
82728 Ferritin (blood protein) level
84550 Uric acid level, blood
82784 Gammaglobulin (immune system protein) measurement
83540 Iron level
82378 Carcinoembryonic antigen (cea) protein level
83550 Iron binding capacity
82607 Cyanocobalamin (vitamin b-12) level
86300 Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3
83521 Measurement of immunoglobulin light chains
84165 Protein measurement, serum
86334 Immunologic analysis technique on serum (immunofixation)
82306 Vitamin d-3 level
96372 Injection of drug or substance under skin or into muscle
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
88184 Flow cytometry technique for dna or cell analysis, first marker
85044 Red blood count, manual test
86301 Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
84443 Blood test, thyroid stimulating hormone (tsh)
96375 Injection of additional new drug or substance into vein
82746 Folic acid level, serum
96413 Administration of chemotherapy into vein, 1 hour or less
99426 Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month
J2405 Injection, ondansetron hydrochloride, per 1 mg
82232 Beta-2 microglobulin (protein) level
86304 Immunologic analysis for detection of tumor antigen, quantitative; ca 125
84153 Psa (prostate specific antigen) measurement, total
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
96361 Infusion into a vein for hydration, each additional hour
85651 Red blood cell sedimentation rate, to detect inflammation, non-automated
J3475 Injection, magnesium sulfate, per 500 mg
81002 Urinalysis, manual test
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
J1200 Injection, diphenhydramine hcl, up to 50 mg
83010 Haptoglobin (serum protein) level
85610 Blood test, clotting time
82533 Cortisol (hormone) measurement, total
83036 Hemoglobin a1c level
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)
86147 Cardiolipin antibody (tissue antibody) measurement
96360 Infusion into a vein for hydration, 31-60 minutes
86146 Beta 2 glycoprotein 1 antibody (autoantibody) measurement
96415 Administration of chemotherapy into vein, each additional hour
96374 Injection of drug or substance into vein
84439 Thyroxine (thyroid chemical), free
96417 Administration of additional new drug or substance into vein, 1 hour or less
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
99195 Drawing of blood for a medical problem
84436 Thyroxine (thyroid chemical), total
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
80047 Blood test, basic group of blood chemicals (calcium, ionized)
85014 Red blood cell concentration measurement
84403 Testosterone (hormone) level, total
80074 Acute hepatitis panel
J7050 Infusion, normal saline solution, 250 cc
82248 Bilirubin level, direct
99439 Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
J1454 Injection, fosnetupitant 235 mg and palonosetron 0.25 mg
G0008 Administration of influenza virus vaccine
82668 Erythropoietin (protein) level
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
99496 Transitional care management services for problem of high complexity
83970 Parathormone (parathyroid hormone) level
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
90662 Influenza vaccine split virus, preservative free
80061 Blood test, lipids (cholesterol and triglycerides)
87529 Detection test by nucleic acid for herpes simplex virus, amplified probe technique
86141 Measurement c-reactive protein for detection of infection or inflammation, high sensitivity
85730 Coagulation assessment blood test, plasma or whole blood
80307 Testing for presence of drug, by chemistry analyzers
96411 Administration of additional new drug or substance into vein using push technique
86038 Screening test for autoimmune disorder
J7030 Infusion, normal saline solution , 1000 cc
81219 Gene analysis (calreticulin), common variants
81270 Gene analysis (janus kinase 2) variant
81279 Gene analysis (janus kinase 2) targeted sequence analysis
81338 Gene analysis (mpl proto-oncogene, thrombopoietin receptor) for detection of common variants
G0452 Molecular pathology procedure; physician interpretation and report
99211 Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional
80048 Blood test, basic group of blood chemicals (calcium, total)
82105 Alpha-fetoprotein (afp) level, serum
99495 Transitional care management services for problem of at least moderate complexity
82785 Ige (immune system protein) level
85536 Blood smear for iron
86431 Rheumatoid factor level
82040 Albumin (protein) level
86618 Analysis for antibody borrelia burgdorferi (lyme disease bacteria)
77080 Dxa bone density measurement of hip, pelvis, spine
87511 Detection test for gardnerella vaginalis (bacteria), amplified probe technique
38222 Biopsy and aspiration of bone marrow sample for diagnosis
87661 Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique
82310 Calcium level, total
87389 Detection test by immunoassay technique for hiv-1 antigen and hiv-1 and hiv-2 antibodies

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.